ID   ProPak-X.36
AC   CVCL_8969
SY   PP-X.36
DR   CLO; CLO_0008489
DR   ATCC; CRL-12007
DR   Wikidata; Q54948372
RX   Patent=US6017761;
RX   PubMed=9231077;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12007.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
RX   Patent=US6017761;
RA   Rigg R.J., Chen J.-Y., Dando J.S., Plavec I., Forestell S.P.,
RA   Bohnlein E.;
RT   "Method for obtaining retroviral packaging cell lines producing high
RT   transducing efficiency retroviral supernatant.";
RL   Patent number US6017761, 25-May-2000.
//
RX   PubMed=9231077; DOI=10.1038/sj.gt.3300420;
RA   Forestell S.P., Dando J.S., Chen J., de Vries P., Bohnlein E.,
RA   Rigg R.J.;
RT   "Novel retroviral packaging cell lines: complementary tropisms and
RT   improved vector production for efficient gene transfer.";
RL   Gene Ther. 4:600-610(1997).
//